citral has been researched along with Breast Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, R; Abu, N; Alitheen, NB; Masarudin, MJ; Mohamad, NE; Nordin, N; Rahman, HS; Yeap, SK; Zamberi, NR | 1 |
| Abasolo, I; Abu-Serie, MM; Andrade, F; Cámara-Sánchez, P; Díaz-Riascos, ZV; Gener, P; Rafael, D; Schwartz, S; Seras-Franzoso, J | 1 |
| Kamalideghan, B; Ky, H; Nigjeh, SE; Nordin, N; Rosli, R; Yeap, SK | 1 |
| Abdullah, R; Abu, N; Alitheen, NB; How, CW; Masarudin, MJ; Mohamad, NE; Nordin, N; Rahman, HS; Yeap, SK; Zamberi, NR | 1 |
| Kapur, A; Patankar, MS; Xiong, MP; Zeng, S | 1 |
| Czarnecki, A; Fass, L; Felder, M; Howell, C; Kapur, A; Kaur, J; Osowski, KK; Patankar, MS; Rathi, K; Whelan, RJ; Xiong, MP; Zeng, S | 1 |
| Coyle, KM; Cruickshank, BM; de Antueno, R; Duncan, R; Giacomantonio, CA; Giacomantonio, MA; Marcato, P; Sultan, M; Thomas, ML | 1 |
7 other study(ies) available for citral and Breast Neoplasms
| Article | Year |
|---|---|
Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Topics: Acyclic Monoterpenes; Animals; Apoptosis; Breast Neoplasms; Cell Movement; Cell Proliferation; Drug Carriers; Female; Humans; Lipids; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasm Invasiveness; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Pluronic F127 micelles improve the stability and enhance the anticancer stem cell efficacy of citral in breast cancer.
Topics: Acyclic Monoterpenes; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Micelles; Neoplastic Stem Cells; Poloxamer | 2021 |
Citral induced apoptosis in MDA-MB-231 spheroid cells.
Topics: Acyclic Monoterpenes; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Monoterpenes; Spheroids, Cellular | 2018 |
In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 8; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Humans; Lipids; Mice; Nanostructures; Neoplasm Invasiveness | 2019 |
Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Enzyme Inhibitors; Female; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Micelles; Monoterpenes; Stereoisomerism; Xenograft Model Antitumor Assays | 2015 |
Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation.
Topics: Acyclic Monoterpenes; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Lactones; Monoterpenes; Nanoparticles; Oxidative Stress; Polyethylene Glycols; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2016 |
Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Topics: Acyclic Monoterpenes; Aldehyde Oxidoreductases; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Fluorescence; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Monoterpenes; Nanoparticles; Neoplastic Stem Cells; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2016 |